This article has been updated with a statement from BGI.
NEW YORK (GenomeWeb) – Illumina said today that it has filed a patent infringement lawsuit against BGI Europe, a subsidiary of BGI Group, in the Maritime & Commercial High Court of Denmark.
According to the complaint, BGI's sequencing products, including the BGISEQ-500 and MGISEQ-2000 instruments and related sequencing chemistry reagents of BGI Group subsidiary MGI Tech, infringe Illumina's European patent EP 3 002 289 B1, which covers sequencing-by-synthesis chemistry.